Nan Fung Group Holdings LTD Rani Therapeutics Holdings, Inc. Call Options Transaction History
Nan Fung Group Holdings LTD
- $103 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
36Shares Held
5.78MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$6.05 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$1.67 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$1.05 Million0.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$711,4460.02% of portfolio
-
Stifel Financial Corp St. Louis, MO270KShares$633,9540.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $57.6M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...